Harmony Biosciences Holdings

HRMY69

$33.04arrow_drop_up0.27%$0.09

HRMY69

$33.04

arrow_drop_up0.27%$0.09

Performance History

Key Stats
Open	$33.00
Prev. Close	$33.00
EPS	2.11
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	33.00	33.00
52 Week Range	18.61	41.57

Ratios







EPS	2.11

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Harmony Biosciences Holdings (HRMY)

Harmony Biosciences Holdings, Inc. is a leading biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for patients with sleep and central nervous system disorders. The company is committed to improving the lives of individuals suffering from these conditions by providing effective and safe treatment options. As a pioneer in the field, Harmony Biosciences has made significant advancements in the understanding and management of sleep disorders.

The stock price history of Harmony Biosciences Holdings, Inc. (HRMY) reflects the growing interest and confidence in the company's potential. Over the years, the stock has experienced both ups and downs, influenced by various market forces and industry trends. Investors have closely followed the stock and its performance, recognizing the value of investing in a company that is dedicated to bringing innovative therapies to market.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Jeffrey M. Dayno M.D.
Headquarters: Plymouth Meeting
Employees: 200
Exchange: NASDAQ

add Harmony Biosciences Holdings to watchlist

Keep an eye on Harmony Biosciences Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Harmony Biosciences Holdings's (HRMY) price per share?

The current price per share for Harmony Biosciences Holdings (HRMY) is $33.04. The stock has seen a price change of $0.09 recently, indicating a 0.27% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Harmony Biosciences Holdings (HRMY)?

For Harmony Biosciences Holdings (HRMY), the 52-week high is $41.57, which is 25.83% from the current price. The 52-week low is $18.61, the current price is 77.53% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Harmony Biosciences Holdings (HRMY) a growth stock?

Harmony Biosciences Holdings (HRMY) has shown an average price growth of -4.94% over the past three years. It has received a score of 56 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Harmony Biosciences Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Harmony Biosciences Holdings (HRMY) stock price performance year to date (YTD)?

As of the latest data, Harmony Biosciences Holdings (HRMY) has a year-to-date price change of 7.31%. Over the past month, the stock has experienced a price change of -6.88%. Over the last three months, the change has been -4.09%. Over the past six months, the figure is 10.65%.

help

Is Harmony Biosciences Holdings (HRMY) a profitable company?

Harmony Biosciences Holdings (HRMY) has a net income of $128.85M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 79.17% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 33.17% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $582.02M, with a revenue growth rate of 32.93%, providing insight into the company's sales performance and growth. The gross profit is $460.79M. Operating income is noted at $192.03M. Furthermore, the EBITDA is $228.32M.

help

What is the market capitalization of Harmony Biosciences Holdings (HRMY)?

Harmony Biosciences Holdings (HRMY) has a market capitalization of $1.87B. The average daily trading volume is 32.94, indicating the stock's liquidity and investor engagement.